Cargando…
Combining precision oncology and immunotherapy by targeting the MALT1 protease
An innovative strategy for cancer therapy is to combine the inhibition of cancer cell-intrinsic oncogenic signaling with cancer cell-extrinsic immunological activation of the tumor microenvironment (TME). In general, such approaches will focus on two or more distinct molecular targets in the maligna...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594517/ https://www.ncbi.nlm.nih.gov/pubmed/36270731 http://dx.doi.org/10.1136/jitc-2022-005442 |